Dergiler / Turkish Neurosurgery / 2020 / Cilt: 30 - Sayı: 6

Ellagic Acid Enhances Antitumor Efficacy of Temozolomide in an in vitro Glioblastoma Model

Sayfa
813–821
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: EA combined with TMZ may have a potential antiproliferative efficacy by inhibiting MGMT expression and activating apoptotic protein, p53 and caspase-3, expression.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIM: To observe the effect of combining ellagic acid (EA), a natural phenol present in fruits and vegetables, and temozolomide (TMZ) on the proliferation and expression profile of C6 glioma cell line.
📊
Temel Bulgular & Veri:MATERIAL and METHODS: Rat C6 glioma cells were treated with 100-μM EA combined with 100 μM TMZ for 24, 48, and 72 hours (h).
💡
Sonuç & Katkı:CONCLUSION: EA combined with TMZ may have a potential antiproliferative efficacy by inhibiting MGMT expression and activating apoptotic protein, p53 and caspase-3, expression.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

AIM: To observe the effect of combining ellagic acid (EA), a natural phenol present in fruits and vegetables, and temozolomide (TMZ) on the proliferation and expression profile of C6 glioma cell line. MATERIAL and METHODS: Rat C6 glioma cells were treated with 100-μM EA combined with 100 μM TMZ for 24, 48, and 72 hours (h). Cell proliferation and p53 and caspase-3 protein levels were evaluated using immunocytochemistry. Multi drug resistance 1 (MDR1), O6-methylguanine-DNA methyltransferase (MGMT), and apoptotic protein (caspase-3 and p53) expressions were assessed using reverse transcription polymerase chain reaction (RT-PCR).RESULTS: EA combined with TMZ conspicuously reduced the cell viability at all incubation times (p<0.001). EA significantly downregulated MGMT expression regardless of the presence of TMZ even at early hours (p<0.001). The combination therapy reduced MDR1 expression only on 48 h in comparison with TMZ alone. EA alone upregulated caspase-3 at 48 h but upregulated p53 at 48 and 72 h. The combined therapy enhanced the immunoreactivities of p53 and caspase-3 proteins independent of the treatment durations but not of the genes. CONCLUSION: EA combined with TMZ may have a potential antiproliferative efficacy by inhibiting MGMT expression and activating apoptotic protein, p53 and caspase-3, expression.

🔖

Bu Makaleye Atıf Yap

ÇETİN, A., BILTEKIN, B. (2020). Ellagic Acid Enhances Antitumor Efficacy of Temozolomide in an in vitro Glioblastoma Model. Turkish Neurosurgery, Cilt: 30 - Sayı: 6, 813–821. https://ajindex.com/articles/404298

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Avgeropoulos NG, Batchelor T: New treatment strategies for malignant gliomas. Oncologist 4:209–224, 1999 2. Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M: MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J ClinOncol 26(13): 2192-2197, 2008 3. Domvri K, Zarogoulidis K, Zogas N, Zarogoulidis P, Petanidis S, Porpodis K, Kioseoglou E, Hohenforst-Schmidt W: Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer. J Cancer 8(18):3648-3656, 2017 4. Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Go VL, Pandol SJ, Gukovskaya AS: Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol 14(23):3672-3680, 2008 5. Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee ShU: Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev 18(1):3-9, 2017 6. He Z, Xiao X, Li S, Guo Y, Huang Q, Shi X, Wang X, Liu Y: Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells. Oncol Lett 14(2):2499-2504, 2017 7. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997-1003, 2005 8. Hermann DM, Kilic E, Spudich A, Kramer SD, Wunderli- Allenspach H, Bassetti CL: Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol 60:489–498, 2006 9. Hodges LM, Markova SM, Chinn LW, Gow JM, Kroetz DL, Klein TE, Altman RB: Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet Genomics 21(3):152-161, 2011 10. Khan N, Afaq F, Mukhtar H: Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis 28(2):233–239, 2007 11. Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, Cass B, Bojanowski MW, Gingras D, Béliveau R: Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 26(4):821–826, 2005 12. Leweke F, Damian MS, Schindler C, Schachenmayr W: Multidrug resistance in glioblastoma. Chemose